We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Zillow
ZG
$7.46B
| $5.35M | 0.01% |
108,721
-11,091
| -9% | -$500K |
|
677
Aptiv
APTV
$9.08B
| $5.33M | 0.01% |
52,224
+16,792
| +47% | +$1.66M |
|
678
Reliance Steel & Aluminium
RS
$20B
| $5.27M | 0.01% |
19,405
+3,293
| +20% | +$815K |
|
679
PMV Pharmaceuticals
PMVP
$72.7M
| $5.26M | 0.01% |
840,816
+342,553
| +69% | +$1.8M |
|
|
ACLX
680
DELISTED
Arcellx
ACLX
| $5.21M | 0.01% |
164,671
+153,922
| +1,432% | +$5.88M |
|
681
Becton Dickinson
BDX
$50.6B
| $5.2M | 0.01% |
19,692
+11,551
| +142% | +$2.93M |
|
682
Qorvo
QRVO
$10.4B
| $5.2M | 0.01% |
50,948
+2,785
| +6% | +$267K |
|
683
Kite Realty
KRG
$5.16B
| $5.18M | 0.01% |
231,700
-1,155
| -0.5% | -$23.8K |
|
|
EA
684
DELISTED
Electronic Arts
EA
| $5.17M | 0.01% |
39,892
-74,459
| -65% | -$9.43M |
|
685
Boyd Gaming
BYD
$5.53B
| $5.16M | 0.01% |
74,454
-8,570
| -10% | -$576K |
|
686
Meritage Homes
MTH
$4.29B
| $5.14M | 0.01% |
72,290
-8,886
| -11% | -$558K |
|
|
PNT
687
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $5.13M | 0.01% |
+565,751
| New | +$4.99M |
|
688
Manitowoc
MTW
$741M
| $5.1M | 0.01% |
271,035
+348
| +0.1% | +$5.62K |
|
689
Bloomin' Brands
BLMN
$686M
| $5.05M | 0.01% |
187,684
+14,739
| +9% | +$369K |
|
690
MacroGenics
MGNX
$257M
| $5.04M | 0.01% |
941,162
-14,730
| -2% | -$90.9K |
|
691
Idacorp
IDA
$7.67B
| $5.02M | 0.01% |
48,969
-4,311
| -8% | -$463K |
|
692
CryoPort
CYRX
$826M
| $5M | 0.01% |
290,000
-74,570
| -20% | -$1.53M |
|
693
Cimpress
CMPR
$2.03B
| $5M | 0.01% |
84,068
+80,214
| +2,081% | +$3.95M |
|
694
Wendy's
WEN
$1.42B
| $4.99M | 0.01% |
229,235
-34,540
| -13% | -$770K |
|
695
TechnipFMC
FTI
$29.4B
| $4.97M | 0.01% |
298,737
-7,277
| -2% | -$103K |
|
696
Ardmore Shipping
ASC
$766M
| $4.96M | 0.01% |
401,891
+159,155
| +66% | +$2.12M |
|
697
Semtech
SMTC
$14.1B
| $4.95M | 0.01% |
194,350
-2,222,992
| -92% | -$48M |
|
698
Western Union
WU
$2.14B
| $4.94M | 0.01% |
420,958
+46,142
| +12% | +$532K |
|
|
WW
699
DELISTED
WW International
WW
| $4.94M | 0.01% |
734,775
-24,874
| -3% | -$176K |
|
|
JWN
700
DELISTED
Nordstrom
JWN
| $4.9M | 0.01% |
239,228
+37,615
| +19% | +$632K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.